Aberrant β-catenin activation promotes tumor metastasis and angiogenesis (70–73), while β-catenin/TCF/LEF-dependent transcription, activated by the PI3K/AKT pathway, enhances VEGF-induced angiogenesis (74). Here, HNF4A is linked to neoplasm.